Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
FDA’s Opdivo Lung Cancer Approval
By
João L. Carapinha
October 11, 2024
The FDA has approved a new treatment regimen using Opdivo (nivolumab) for resectable non-small cell lung cancer (NSCLC), marking a significant advancemen...
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Global Health through Regulatory Collaboration
The Trump Drug Policy Change: A Reverse Course
Alzheimer’s Treatments: Evaluating Emerging Therapies and NICE’s ...
Artificial Intelligence in Elderly Care: Ethical and Responsible Adoption
NICE Recommends Abaloparatide for Osteoporosis in the Elderly
Elderly Technology Acceptance: Enhancing Health and Independence
New Innovations in Elderly Healthcare: Latest PBAC Outcomes
Caring for an Ageing US Population: Challenges and Innovations
ABRE Study: Optimising Treatment for Iliofemoral Venous Obstruction
Addressing the Challenges of Value Attribution in Combination Therapies
HPV Vaccination Coverage in Japan: Challenges and Future Directions
« Previous
1
…
6
7
8
9
10
…
17
Next »